ISSN# 1545-4428 | Published date: 19 April, 2024
You must be logged in to view entire program, abstracts, and syllabi
At-A-Glance Session Detail
   
Hepatopancreaticobiliary Malignancies I
Digital Poster
Body
Wednesday, 08 May 2024
Exhibition Hall (Hall 403)
15:45 -  16:45
Session Number: D-40
No CME/CE Credit

Computer #
3993.129Prognostic Performance of LI-RADS v2018 Features and Clinical-Pathological Factors in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma
Leyao Wang1, Sicong Wang2, Xiaohong Ma1, and Xinming Zhao1
1National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 2GE healthcare, MR Research China, Beijing, China

Keywords: Liver, Liver

Motivation: Evaluate the performance of the LI-RADS v2018 features and clinical-pathological factors for predicting the prognosis of AFP-negative HCC.

Goal(s): To evaluate the performance of the LI-RADS v2018 features and clinical-pathological factors for predicting the prognosis of AFP-negative HCC.

Approach: A total of 169 AFP-negative HCC patients were enrolled. Risk factors associated with prognosis were identified by Cox regression analysis.

Results: Six risk factors, namely the LI-RADS category, blood products in mass, MVI, tumor size, cirrhosis, and ALBI grade, were associated with recurrence-free survival. The model effectively stratified patients with AFP-negative HCC into high- and low-risk groups with significantly different outcomes (p < 0.05).

Impact: In this study, our prognostic model composed of the LI-RADS category, blood products in mass, MVI, tumor size, cirrhosis, and ALBI grade accurately classified patients into different recurrence risk groups.

3994.
130Detection Limits and Assessment of the Hepatocellular Content of Lipids using Deuterium Metabolic Imaging: a Pilot Study.
Lorenz Pfleger1, Clemens Baumgartner1, Peter Wolf1, Thomas Scherer1, Wolfgang Bogner2, Fabian Niess2, Siegfried Trattnig2, and Martin Krššák1,2
1Medicine III, Division of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria, 2Biomedical Imaging and Image-guided Therapy, High-Field MR Center, Medical University of Vienna, Vienna, Austria

Keywords: Liver, Deuterium, Liver, DMI

Motivation: While HCL can be assessed in vivo using 1H-MRS it may be of interest to determine it with DMI, as this offers the possibility for dynamic studies with incorporation of deuterated substances.

Goal(s): Our goal was to explore the detection limits and estimate HCL based on DMI.

Approach: 10 healthy subjects were measured in a 7T-MR-system with liver adjusted RF surface coil applying a single-voxel 1H-MRS-GUSTEAU sequence and a 2H-MRSI sequence. HCL was assessed by comparison with the water signal from both measurements. 

Results: The HCL values were underestimated when applying DMI compared to the well-established 1H-MRS ultra-short echo time GUSTEAU sequence.

Impact: Besides the use of 1H-MRS, HCL can also be assessed with DMI. Due to the much lower natural abundance of 2H compared to 1H, the detection limit for 2H-HCL was estimated to be ≥1%.

3995.
131Quantitative MRI to evaluate the efficacy of immunotargeted therapy in unresectable hepatocellular carcinoma
Yu-chen Wei1, Yan-sha Wei2, Kan Deng3, and Jin-yuan Liao4
1Department of Radiology, The First Affiliated Hospital of Guangxi Medical University, NanNing, China, 2Department of Radiology, The People’s Hospital of Guangxi Zhuang Autonomous Region, NanNing, China, 3Philips Healthcare, Guangzhou, China, 4Department of Radiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China

Keywords: Liver, MR Value, Hepatocellular Carcinoma; immunotargeted therapy; MRI; Quantitative parameters

Motivation: Quantitative MRI maybe helpful for evaluating the immunotargeted therapy efficacy in unresectable HCC.

Goal(s): To investigate the feasibility of quantitative MRI parameters for evaluating the immunotargeted therapy efficacy in unresectable HCC

Approach: Statistics analysis was used to  study the alterations in patients with unresectable HCC at baseline and 2 months, 4 monthsafter immunotherapy

Results: The ADC value of HCC increased,the longest diameter of HCC initially increased and then decreased. The ADC value and ΔT1% of HCC target lesions in partial response group increased significantly. In progressive disease group, the ΔT1% of HCC target lesions decreased significantly, and ADC values showed a downward trend.

Impact: This is the first report to evaluate the immunotargeted therapy in unresectable HCC using quantitative MRI techniques.

3996.132Optimizing b-value Selection in MRI Diffusion Parameters for Hepatocellular Carcinoma: A Comparative Study of IVIM, DKI, and CTRW Models
Fan Zhang1, Gen Chen1, Zixiong Wang1, Mnegqi Huang1, Ting Yin2, Wei Chen2, and Xuemei Hu1
1Huazhong University of Science and Technology, Wuhan, China, 2MR Research Collaborations, Siemens Healthineers Ltd., Shanghai, China

Keywords: Liver, Body

Motivation: Streamlining the number of b-values in MRI scans for hepatocellular carcinoma can significantly enhance diagnostic efficiency.

Goal(s): To identify the minimal b-value pairs that correspond with comprehensive diffusion model parameters, potentially simplifying future scanning protocols.

Approach: Employed MRI diffusion parameters across 11 b-values in 35 patients, comparing IVIM, DKI, and CTRW metrics with sADC values derived from varied b-value combinations.

Results: Discovered specific b-value pairs that closely matched the diffusion parameters of comprehensive models, suggesting a possible reduction in required b-values for accurate diagnosis.

Impact: This study could substantially refine MRI protocols, improving tumor characterization and grading while ensuring data quality with fewer b-values.

3997.
133The differential diagnostic value of APT combined with Gd-BOPTA in IMCC and SHHM.
Yiran Xu1, Jun Li2, Ying Zhao2, Xue Ren2, Ailian Liu2, and Liangjie Lin3
1School of Medical Imaging,Dalian Medical University, Dalian, China, 2Department of Radiology, The First Affiliated Hospital of Dalian Medical University, Dalian, China, 3Philips (China) Investment Co., Ltd, Shanghai, China

Keywords: Hepatobiliary, Precision & Accuracy, Differential diagnosis

Motivation: IMCC and SHHM have similarities in imaging manifestations, are prone to confusion, and the treatment methods are different, once misdiagnosed, it seriously affects the patient's treatment and prognosis.

Goal(s): This study aims to explore the differential diagnostic value of amide proton transfer (APT) combined with Gd-BOPTA in IMCC and SHHM.

Approach: Retrospective analysis, normality testing, logistic regression, ROC analysis, and other methods were used for the study.

Results: APT, LLR, and LSIR have significance in the differential diagnosis of IMCC and SHHM. When combined with LLR and LSIR, APT improves the differential efficiency.

Impact: This study helps to more accurately distinguish IMCC from SHHM, thus adopting the correct treatment method, which is of great help to the treatment and prognosis of patients.

3998.
134Differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma using MRI and clinical-based nomogram model
Zheng Zhu1, Lina Hou2, Yanfeng Zhao1, and Xinming Zhao1
1National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 2Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, China

Keywords: Liver, Tumor

Motivation: Hepatic hyperintense lesions, has been shown to be difficult for differential diagnosis in clinical. 

Goal(s): Multiple parameters MRI can potentially provide whole insights into hepatic lesion diagnosis. 

Approach: 144 patients based on hepatic hyperintense lesions (HCA and WDHCC) with presurgical MRI to investigate the differential diagnosis. 

Results: Results demonstrated that MRI signal model can provide more effective information for the differential diagnosis of hepatic hyperintense lesions especially for HCA and WDHCC.

Impact: Differentiating Hepatocellular adenomas (HCA) and well-differentiated hepatocellular carcinoma (WDHCC) via MRI signal-based model could offer a more comprehensive diagnostic approach than clinical factors-based model and combined MRI signal plus clinical factors-based model.

3999.
135Diffusion–Based Virtual MR Elastography as a Potential Biomarker for Predicting Recurrence of Hepatocellular Carcinoma
Chen Jiejun1, Sun Wei1, Wang Wentao1, Fu Caixia2, and Rao Shengxiang1
1Zhongshan hospital, Fudan University, Shanghai, China, 2MR Application Development, Siemens Shenzhen Magnetic Resonance Ltd., Shenzhen, China

Keywords: Liver, Liver

Motivation: Preoperative prediction of tumor recurrence is essential for surveillance and management of patients with hepatocellular carcinoma (HCC).

Goal(s): To explore the diagnostic performance of virtual magnetic resonance elastography (vMRE) derived from preoperative diffusion-weighted images in predicting HCC recurrence after hepatectomy.

Approach: Eighty patients who underwent magnetic resonance imaging with a dedicated diffusion-weighted imaging sequence were retrospectively recruited. The parameters derived from vMRE, together with image features, were used to predict tumor recurrence after hepatectomy.

Results: The μdiff values of vMRE and corona enhancement are potential biomarkers for the preoperative prediction of recurrence after hepatectomy in patients with HCC.

Impact: Our results revealed that preoperative diffusion–based virtual magnetic resonance elastography could be used for preoperative prediction of HCC recurrence without using additional hardware, which might help in deciding on treatment and formulating management strategies for patients with HCC.

4000.
136Differentiation between inflammatory myofibroblastic tumor and colorectal liver metastasis on gadoxetic acid-enhanced MRI
Jinkui Li1, Junqiang Lei1, and Yi Zhu2
1The First Hospital of Lanzhou University, Lanzhou, China, 2Philips Healthcare, Beijing, China

Keywords: Hepatobiliary, Tumor, hepatic inflammatory myofibroblastic tumor

Motivation: Inflammatory myofibroblastic tumors (IMT) of the liver can mimic malignant tumors, yet, they lack definitive radiological characteristics.

Goal(s): To identify gadoxetate acid-enhanced MRI (Gd-EOB-MRI) features distinguishing hepatic inflammatory myofibroblastic tumor (IMT) from colorectal liver metastasis (CLM).

Approach: This retrospective study included 10 IMT (0.7-7.1 cm) and 28 CLM (0.4-5.4 cm) patients who underwent Gd-EOB-MRI. Two reviewers assessed tumor characteristics.

Results: Peripheral hypointense rim on T1WI, and arterial phase and/or portal venous phase, corresponding to the delayed enhanced rim on transitional phase, layered appearance  on T2WI, and obscure hypointensity on hepatobiliary phase were commonly in IMTs, but rare in CLMs.

Impact: The distinctive imaging features on Gd-EOB-DTPA MRI such as early target appearance and delayed enhanced rim and obscure hypointensity on Hepatobiliary phase, are helpful in  differential diagnosis of IMT from colorectal liver metastasis.

4001.
137Sensitivity and Specificity of Detecting Premalignant Pancreatic Lesions by Hyperpolarized Magnetic Resonance
Jose Santiago Enriquez1,2, Rian M. Howell2,3, Olivereen Le Roux3, Shivanand Pudakalakatti1, Prasanta Dutta1, Erzsébet Merényi4, Florencia McAllister2,3, and Pratip K. Bhattacharya1,2
1Cancer System Imaging, UT MD Anderson Cancer Center, Houston, TX, United States, 2UT MD Anderson Cancer Center UT Health Science Center Houston Graduate School of Biomedical Sciences, Houston, TX, United States, 3Clinical Cancer Prevention, UT MD Anderson Cancer Center, Houston, TX, United States, 4Statistics, Rice University, Houston, TX, United States

Keywords: Pancreas, Hyperpolarized MR (Non-Gas), Pancreatic Cancer, Metabolic Imaging, Early Detection

Motivation: There is an unmet need for early diagnosis of pancreatic cancer due to the asymptomatic nature of the disease.

Goal(s): The goal is to detect the early stages of pancreatic cancer by monitoring the altered metabolism in premalignant pancreatic lesions in vivo with hyperpolarized metabolic imaging.

Approach: This is validated in two mechanistic pathways of cancer progression, (1) pancreatic intraepithelial neoplasia (PanIN), and (2) intraductal papillary mucinous neoplasm (IPMN).

Results: Increased lactate flux is observed with progression of the premalignant lesions in both the pathways. No increase in lactate flux is observed in pancreatitis, a known confounder demonstrating the specificity of this technique.

Impact: This research described has the potential for leading to practice-changing recommendations for non-invasively detecting and monitoring premalignant lesions and incipient pancreatic cancer, to prevent over-diagnosis and over-treatment of cysts that harbor indolent biology. 

4002.
138Elevation of HCC perfusion by diffusion-derived vessel density (DDVD) biomarker: Higher HCC perfusion than earlier IVIM reports.
Dian-Qi Yao1, Xin-Ming Li2, Hao-Jun Lu2, Wei-Bo Chen3, Xian-Yue Quan2, and Yi-Xiang Wang1
1Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong, China, 2Department of Radiology, Zhujiang Hospital, Southern Medical University, GuangZhou, China, 3Philips Healthcare, Shanghai, China

Keywords: Liver, Diffusion/other diffusion imaging techniques, diffusion; perfusion; MR imaging

Motivation: HCCs mostly show higher perfusion values compared with the adjacent normal liver tissue. Paradoxically authors reported a decrease IVIM-PF(perfusion fraction) of HCC relative to adjacent liver.

Goal(s): DWI-derived surrogate biomarker DDVD (diffusion-derived vessel density) is a physiological surrogate of the area of micro-vessels per unit tissue area.  This study applied DDVD to assess perfusion of HCC. 

Approach: 72 patients were included. DDVD= (signal intensity at b=0)/ROIarea – (signal intensity at b=2/ROIarea). 

Results: (tumor DDVD)/(liver DDVD) was 2.942 (median), majority of HCC showing a much higher DDVD than liver.

Impact: DDVD overcome the pitfalls associated with IVIM PF.

4003.
139Predicting the Degree of Differentiation of Pancreatic Cancer: A Comparative Study of Four MRI Diffusion Models
Ya Lan1, Jie Chen2, Jinggang Zhang2, Fuyao Liu2, Derui Hu2, Qi Jiang2, Mingming Yang2, Yunzhu Wu3, Xu Yan3, and Guang Yang4
1Changzhou Medical Center, Nanjing Medical University, Changzhou, China, 2The Third Affiliated Hospital of Soochow University, Changzhou, China, 3MR Research Collaboration Team, Siemens Healthineers Ltd., Shanghai, China, 4Shanghai Key Laboratory of Magnetic Resonance, East China Normal University, Shanghai, China

Keywords: Pancreas, Diffusion/other diffusion imaging techniques, Pancreatic ductal adenocarcinoma; FROC;CTRW;Differentiation

Motivation: This study aims to determine the value of diffusion kurtosis imaging (DKI), intro-voxel incoherent movement (IVIM), continuous-time random walk (CTRW), and fractional order calculus (FROC) in assessing the degree of differentiation of pancreatic cancer.

Goal(s): The objective is to identify the most effective quantitative diffusion metrics for assessing the degree of differentiation in pancreatic cancer.

Approach: Four MRI diffusion models were generated using DXI technology to quantitatively evaluate the degree of differentiation in pancreatic cancer.

Results: Significant differences were observed between the low-grade PDAC group and the high-grade PDAC group in terms of these metrics (KDKI, αCTRW, μFROC).

Impact: These advanced diffusion models hold potential as noninvasive tools for predicting the degree of differentiation in pancreatic cancer, facilitating personalized management strategies for patients with pancreatic ductal adenocarcinoma (PDAC).

4004.
140Investigation of clinical applicability of multi-parametric 4D-MRI for radiotherapy in liver cancer
Sha Li1,2, Xianggao Zhu2, Chen Zhang3, Tian Li4, and Yanye Lu1
1Institute of Medical Technology, Peking University Health Science Center, Beijing, China, 2Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education / Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing Cancer Hospital & Institute, Beijing, China, 3MR Scientific Marketing, Digital Imaging, Siemens Healthineers Ltd, Beijing,China, Beijing, China, 4Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, Hong Kong, China

Keywords: Cancer, Cancer

Motivation: Although many methods for generating 4D-MRI have been studied, there are few clinical applications for radiotherapy based on 4D-MRI.

Goal(s): To investigate the clinical potential of multi-parametric 4D-MRI in liver cancer radiotherapy.

Approach: Target contours were delineated on the planning CT with assisted by 3D-MRI and multi-parametric 4D-MRI. Clinical plans were designed based on these contours respectively. Target volume and contours in three different hepatic lobes and target dose were compared and evaluated.

Results: 3D image-guided target delineation may be more likely to underestimate target volume and compromise dose coverage.

Impact: Multi-parametric 4D-MRI can be applied in clinical radiotherapy, which provides more accurate target delineation and dose coverage.

4005.
141Comparison of Abbreviated MRI with Hepatobiliary Phase Sequences versus Full Protocol MRI in Post-Microwave Ablation Surveillance of HCC
Pedram Keshavarz1, Kevin King1, Jena Depetris1, Matthew Quirk1, Tae Wook Kang1, James Sayre1, Steven Raman1, and David Lu1
1UCLA, Los Angeles, CA, United States

Keywords: Hepatobiliary, Tumor

Motivation: The study seeks to validate an abbreviated MRI protocol for HCC post-treatment surveillance.

Goal(s): To determine whether an abbreviated MRI protocol is as effective as full protocol MRI for HCC surveillance post-MWA.

Approach: A retrospective cohort study comparing abbreviated MRI to full protocol MRI in detecting HCC recurrence after microwave ablation.

Results: The abbreviated MRI achieved an acceptable sensitivity, specificity, and negative predictive value, specificity in detecting local HCC recurrences post-MWA, indicating effective secondary surveillance potential.

Impact: The study demonstrates that abbreviated MRI can effectively monitor HCC post-treatment, offering a less burdensome and cost-effective surveillance method with high accuracy, paving the way for streamlined clinical monitoring protocols.

4006.
142Evaluation of imaging features and prognosis of CK19-positive small hepatocellular carcinoma patients based on gadoxetic acid enhanced MRI
maotong liu1, Tao zhang1, Xue-Qin Zhang1, and Xian-ce Zhao2
1Affiliated Nantong Hospital 3 of Nantong University, Nantong, China, 2Philips Healthcare, Shanghai, China

Keywords: Hepatobiliary, Biliary

Motivation: HCC expressing CK19-positive has a poor prognosis, and accurate preoperative prediction of CK19 is essential for determining the prognosis and treatment options for HCC patients

Goal(s): To explore the prognostic factors of CK19-positive small HCC

Approach: In this study, a nomogram to predict C19-positive small HCC was successfully constructed, and predictive factors for early recurrence in patients with C19-positive small HCCwere clarified.

Results: Rim APHE may help to predict early (2 years) postoperative recurrence in patients with CK19-positive small HCC (≤3 cm).

Impact: In this study, a nomogram to predict CK19-positive small HCC was successfully constructed, and predictive factors for early recurrence in patients with C19-positive small HCC were clarified.

4007.
143The GRAPH-CRAFITY Score: a novel prognostic tool for patients with hepatocellular carcinoma treated with targeted therapy and immunotherapy
Ying Xu1, Yi Yang1, Lu Li1, Sicong Wang2, Lizhi Xie2, Feng Ye1, and Xinming Zhao1
1Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 2Magnetic Resonance Imaging Research, General Electric Healthcare, Beijing, China, Beijing, China

Keywords: Liver, Liver, Hepatocellular Carcinoma, Targeted Therapy, Immunotherapy, Prognostic Prediction ·

Motivation: Biomarkers that predict the efficacy of immunotherapy-based systematic therapy remain an unmet need in HCC. 

Goal(s): To establish an optimized model by integrating magnetic resonance (MR) features and CRAFITY score to predict overall survival (OS) of HCC patients treated with targeted therapy and immunotherapy. 

Approach: The clinical variables and MR features were assessed by univariate and multivariate Cox regression analyses. 

Results: Based on independent risk factors (Gender, intRatumoral fAt, enhancing tumor caPsule, gross growtH type and CRAFITY Score) identified by the multivariate analysis, a novel prognostic tool named GRAPH-CRAFITY Score was developed to predict OS.

Impact: A novel prognostic tool by integrating gender, MR features and laboratory tests was developed to predict OS of HCC patients treated with targeted therapy and immunotherapy, which will help oncologists for decision-making.